Concepedia

Tocilizumab: An Effective Therapy for Severely and Critically Ill COVID-19 Patients

Ajeet Singh, Sudhir Bhandari, Govind Rankawat

Indian Journal of Critical Care Medicine · 2021 · 23 citations · 17 references

DOIFull text

Open access

Concepts

Abstract

Bhandari S, Rankawat G, Singh A. Tocilizumab: An Effective Therapy for Severely and Critically Ill COVID-19 Patients. Indian J Crit Care Med 2021;25(3):260-266.

References

17

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Nanshan Chen, Min Zhou, Xuan Dong et al. · The Lancet · 2020 · 22.7K citations · Full text

, , +13

The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care.

Susan P. Baker, Brian O’Neill, William F. Haddon et al. · PubMed · 1974 · 8K citations

, , +17

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Jun Lan, Jiwan Ge, Jinfang Yu et al. · Nature · 2020 · 6.7K citations · Full text

, , +17

Effective treatment of severe COVID-19 patients with tocilizumab

Xiaoling Xu, Mingfeng Han, Tiantian Li et al. · Proceedings of the National Academy of Sciences · 2020 · 2.8K citations · Full text

, , +17

Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality

Chi Zhang, Zhao Wu, Jiawen Li et al. · International Journal of Antimicrobial Agents · 2020 · 1.8K citations · Full text

, , +14